Crinetics Pharmaceuticals, Inc.
FORMULATIONS OF A SOMATOSTATIN MODULATOR

Last updated:

Abstract:

Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.

Status:
Application
Type:

Utility

Filling date:

7 Sep 2021

Issue date:

10 Mar 2022